Patents by Inventor Jin Ding

Jin Ding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12112722
    Abstract: An adaptive adjustment system and method for the brightness of a holographic waveguide display device is provided. The adaptive adjustment system includes five functional modules: a computer control module, a driving and adjustment module, a micro image source display module, an optical waveguide transmission module and an ambient light acquisition module. A video signal is provided by the computer control module and is then transmitted under the control of the driving and adjustment module to illuminate the micro image source display module, and light information of the micro image source display module is finally transmitted to human eyes by means of the optical waveguide transmission module to realize display. The ambient light acquisition module is used for acquiring environmental illuminance information and transmitting the environmental illuminance information to the driving and adjustment module to change the brightness of the micro image source display module.
    Type: Grant
    Filed: December 29, 2022
    Date of Patent: October 8, 2024
    Assignee: SOUTHEAST UNIVERSITY
    Inventors: Yuning Zhang, Zhuang Liu, Jin Ding
  • Publication number: 20240331658
    Abstract: An adaptive adjustment system and method for the brightness of a holographic waveguide display device is provided. The adaptive adjustment system includes five functional modules: a computer control module, a driving and adjustment module, a micro image source display module, an optical waveguide transmission module and an ambient light acquisition module. A video signal is provided by the computer control module and is then transmitted under the control of the driving and adjustment module to illuminate the micro image source display module, and light information of the micro image source display module is finally transmitted to human eyes by means of the optical waveguide transmission module to realize display. The ambient light acquisition module is used for acquiring environmental illuminance information and transmitting the environmental illuminance information to the driving and adjustment module to change the brightness of the micro image source display module.
    Type: Application
    Filed: December 29, 2022
    Publication date: October 3, 2024
    Applicant: SOUTHEAST UNIVERSITY
    Inventors: Yuning ZHANG, Zhuang LIU, Jin DING
  • Publication number: 20240307564
    Abstract: The present disclosure provides herein conjugates of anti-CLDN18.2 antibodies or antigen-binding fragments thereof with radionuclides, the pharmaceutical composition containing the same and the uses thereof in imaging, patient screening, treatment process monitoring and efficacy evaluation.
    Type: Application
    Filed: February 18, 2022
    Publication date: September 19, 2024
    Inventors: Xueming QIAN, Hua ZHU, Fei TENG, Hongjun LI, Zhi YANG, Yi GU, Jin DING, Feng WANG
  • Publication number: 20240299495
    Abstract: A stabilized aPGF composition or a method for stabilization of the pharmaceutical composition comprising aFGF are provided. The composition comprises aPGF, a citric acid compound and other excipients. The method for improving stability of aPGF in the form of a liquid formulation or a lyophilized formulation so as to increase storage stability is also provided.
    Type: Application
    Filed: May 28, 2024
    Publication date: September 12, 2024
    Applicant: EUSOL BIOTECH CO., LTD.
    Inventor: Jin-Ding HUANG
  • Patent number: 11638892
    Abstract: A high-adsorption-performance nanofiber filter medium includes a support material and a composite nanofiber filtration layer that includes multiple nanometer composite nanofiber layers deposited and stacked on the support material. The nanometer composite nanofiber layer includes first, second, and third nano-powder composite nanofibers, which are uniformly mixed by means of an airflow or are sequentially laminated to form the nanometer composite nanofiber layer. The nanometer composite nanofiber layer formed through sequential lamination includes first, second, and third nanofiber layers. The first nanofiber layer includes multiple first nano-powder composite nanofibers. The second nanofiber layer is stacked on the first nanofiber layer and includes multiple second nano-powder composite nanofibers. The third nanofiber layer is stacked on the second nanofiber layer and includes multiple third nano-powder composite nanofibers.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: May 2, 2023
    Assignee: CHANG-FONG TEXTILE TECHNOLOGY CO., LTD.
    Inventor: Jin-Ding Chen
  • Publication number: 20220152153
    Abstract: A stabilized aFGF composition or a method for stabilization of the pharmaceutical composition comprising aFGF are provided. The composition comprises aFGF, a citric acid compound and other excipients. The method for improving stability of aFGF in the form of a liquid formulation or a lyophilized formulation so as to increase storage stability is also provided.
    Type: Application
    Filed: November 15, 2021
    Publication date: May 19, 2022
    Applicant: EUSOL BIOTECH CO., LTD.
    Inventor: Jin-Ding HUANG
  • Publication number: 20220071987
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: September 22, 2021
    Publication date: March 10, 2022
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
  • Patent number: 11241424
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Grant
    Filed: December 30, 2019
    Date of Patent: February 8, 2022
    Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.
    Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr Tsai, Shu-Wen Kuo, Yu-En Tien
  • Patent number: 11234974
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: February 1, 2022
    Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.
    Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr. Tsai, Shu-Wen Kuo, Yu-En Tien
  • Publication number: 20220023783
    Abstract: A high-adsorption-performance nanofiber filter medium includes a support material and a composite nanofiber filtration layer that includes multiple nanometer composite nanofiber layers deposited and stacked on the support material. The nanometer composite nanofiber layer includes first, second, and third nano-powder composite nanofibers, which are uniformly mixed by means of an airflow or are sequentially laminated to form the nanometer composite nanofiber layer. The nanometer composite nanofiber layer formed through sequential lamination includes first, second, and third nanofiber layers. The first nanofiber layer includes multiple first nano-powder composite nanofibers. The second nanofiber layer is stacked on the first nanofiber layer and includes multiple second nano-powder composite nanofibers. The third nanofiber layer is stacked on the second nanofiber layer and includes multiple third nano-powder composite nanofibers.
    Type: Application
    Filed: July 21, 2020
    Publication date: January 27, 2022
    Inventor: JIN-DING CHEN
  • Patent number: 10946062
    Abstract: Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: March 16, 2021
    Assignee: EUSOL BIOTECH CO., LTD.
    Inventors: Jin-Ding Huang, Wan-Ya Chang, Che-Ming Yeh
  • Patent number: 10806877
    Abstract: A portable breathing machine includes a body case (100), wherein: a fan box (101), a cut-off device (108) and a control device (113) are arranged in the body case (100); a fan (8) is arranged in the fan box (101) through a fan noise reduction device (102); an air outlet of the fan box (101) is connected with an internal breathing tube (107); the cut-off device (108) is arranged on the internal breathing tube (107); an air outlet of the cut-off device (108) is connected with an external breathing tube (104) and a mask (105); the fan noise reduction device (102) includes a lower flexible cover (3) and an upper flexible cover (5); the lower and upper flexible covers cooperate to form an enclosed cavity for containing the fan (8). A working noise of the breathing machine is decreased to below 15 decibel.
    Type: Grant
    Filed: March 22, 2016
    Date of Patent: October 20, 2020
    Assignee: MICOMME MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.
    Inventors: Zheng Dai, Jin Ding, Wei Liu, Qinpeng Xu, Haoxuan Huang, Weili Li, Chao He, Menghang Lei, Xiaohui Zeng, Guangrong Wang
  • Publication number: 20200276264
    Abstract: Disclosed are methods and compositions useful in preventing or treating a metabolic disorder by using a protein having an amino acid sequence as set forth in SEQ ID NO: 1.
    Type: Application
    Filed: February 26, 2020
    Publication date: September 3, 2020
    Applicant: Eusol Biotech Co., Ltd.
    Inventors: Jin-Ding Huang, Wan-Ya Chang, Che-Ming Yeh
  • Publication number: 20200179373
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: February 18, 2020
    Publication date: June 11, 2020
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
  • Publication number: 20200179372
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: December 30, 2019
    Publication date: June 11, 2020
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
  • Publication number: 20200030318
    Abstract: The present invention relates to kits and prefilled syringes comprising pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as methods of treating pain using such formulations.
    Type: Application
    Filed: September 30, 2019
    Publication date: January 30, 2020
    Inventors: Chan-Jung LI, David Chih-Kuang CHOU, Jin-Ding HUANG, Shin-Jr TSAI, Shu-Wen KUO, Yu-En TIEN
  • Patent number: 10407886
    Abstract: The present invention includes a toilet pool, wherein the toilet pool has a pool tapered from top to bottom, the bottom of the pool is a discharge outlet, the top of the pool is a tapered annular platform, the tapered annular platform consists of a wide part and a narrow part, above the tapered annular platform is a slot flush nozzle, shunts implemented by the slot flush nozzle are evenly distributed on a surface of the pool under the guide of the tapered annular platform, and the toilet pool is provided with a clean water supply. It achieves a configuration that two flushing systems coexist on a toilet pool, achieves secondary homogenization of water currents, achieves water-saving and efficient flushing, achieves maximization of water capacity in the same space, and achieves a simple, reliable fixedly-installed toilet.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: September 10, 2019
    Assignee: QINGDAO CHUANGHUI INDUSTRY CO., LTD.
    Inventors: Limin Ding, Jinghe Wang, Jinning Ding, Guifen Bai
  • Patent number: 10355340
    Abstract: A lighting device is disclosed. The lighting device comprises: a solid-state lighting element; a radio frequency communication unit for wireless communication between the lighting device and an external device; a light guide having a circumferential edge, wherein the light guide is adapted to couple in light emitted by the solid-state lighting element and to provide illumination to the surroundings of the lighting device; and a metal strip extending along at least a portion of the circumferential edge of the light guide, wherein the metal strip is in thermal contact with the solid-state lighting element and the light guide, and wherein the metal strip is coupled to the radio frequency communication unit so as to operate as an antenna for the radio frequency communication unit.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: July 16, 2019
    Assignee: SIGNIFY HOLDING B.V.
    Inventors: Antonius Adrianus Maria Marinus, Yacouba Louh, Jin Ding
  • Publication number: 20190160053
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Application
    Filed: November 19, 2018
    Publication date: May 30, 2019
    Inventors: Chan-Jung LI, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr Tsai, Shu-Wen Kuo, Yu-En Tien
  • Patent number: 10183018
    Abstract: The present invention relates to injectable, extended-release, pharmaceutical formulations comprising a nalbuphine ester prodrug homogenously dissolved in a solution comprising a pharmaceutically acceptable oil and an oil-miscible retaining solvent, as well as manufacturing processes and medical uses of the formulations. The invention further provides methods for adjusting the duration of action of the formulations by varying the ratio of the pharmaceutically acceptable oil and the oil-miscible retaining solvent.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: January 22, 2019
    Assignees: Lumosa Therapeutics Co., Ltd., Shanghai Lumosa Therapeutics Co., Ltd.
    Inventors: Chan-Jung Li, David Chih-Kuang Chou, Jin-Ding Huang, Shin-Jr. Tsai, Shu-Wen Kuo, Yu-En Tien